INS World Congress 2026: Insights from Lisbon
The 17th World Congress of the International Neuromodulation Society (INS) took place in Lisbon, Portugal, from 9–14 May 2026, bringing together global experts to discuss the latest advancements in the field. Representing our society, our Immediate Past President Dr Michelle O’Brien was in attendance to experience the cutting-edge research, clinical updates, and global collaborations firsthand. Dr O’Brien has put together a comprehensive summary of the event.
Deloitte Access Economics Report: Cost effectiveness of pain devices
The Neuromodulation Society of Australia and New Zealand (NSANZ), engaged Deloitte Access Economics to estimate the cost effectiveness of neuromodulation treatment through spinal cord stimulation (SCS) and intrathecal pumps, which are collectively referred to as pain devices.
Private Health Insurance Policies
Potential differences in Private Health Insurance policy coverage for Pain Management with/without device and other selected categories
